|
PEA
|
Placebo
|
---|
Baseline
|
Week 4
|
Week 8
|
Baseline
|
Week 4
|
Week 8
|
---|
Total Sleep time (hrs)
|
7.49 ± 1.1
|
7.66 ± 1.2
|
7.58 ± 1.1
|
7.52 ± 1.2
|
7.54 ± 1.2
|
7.48 ± 1.1
|
Sleep Time (hrs)
|
7.00 ± 1.0
|
7.10 ± 1.0
|
7.03 ± 1.1
|
6.98 ± 1.2
|
7.02 ± 1.2
|
6.97 ± 1.1
|
Interruptions (min)
|
34.3 ± 14.1
|
32.3 ± 11.6
|
32.2 ± 11.2
|
32.1 ± 12.2
|
31.3 ± 12.4
|
30.9 ± 11.8
|
Sleep quality (1–5)
|
2.7 ± 0.6
|
3.1 ± 0.7
|
3.1 ± 0.7
|
2.5 ± 0.7
|
3.0 ± 0.7
|
2.9 ± 0.9
|
Sleep Continuity (1–5)
|
3.2 ± 0.9
|
3.2 ± 0.9
|
3.2 ± 0.9
|
3.2 ± 0.9
|
3.4 ± 1.0
|
3.3 ± 0.9
|
Sleep Percentage (%)
|
92.4 ± 3.9
|
92.9 ± 3.0
|
92.8 ± 2.4
|
92.8 ± 3.0
|
91.1 ± 7.5
|
93.0 ± 2.9
|
- N.B. Data presented as mean ± standard deviation; total sleep time = sleep time + interruptions + sleep latency; PEA palmitoylethanolamide